WAFF reports – HudsonAlpha working with Huntsville Hospital, iRepertoire to develop COVID-19 treatment


Researchers at the HudsonAlpha Institute for Biotechnology are continuing to study virus-fighting antibodies from COVID-19 survivors in hopes of soon developing a cure.

Rick Myers, PhD, spoke with WAFF about how researchers will use blood samples from Huntsville Hospital COVID-19 patients to study how the immune system interacts with the virus, and then use that information to hopefully develop a treatment.

“This is a particularly directed project to take blood from people who have been infected with the virus,” said Myers. “You try to take it at the beginning of their infection, so right when they come in to the hospital. Then you take blood again a few days later and then a few days later.”

Watch the full interview from WAFF.